EDMONTON, Jan. 6 /CNW/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that it has exercised its option to purchase additional equity in BioCyDex Inc., a private company based in Edmonton, bringing BioMS Medical’s total equity position to 49%.
